Neutrophil activation by plasma opsonized polymeric microspheres: Inhibitory effect of Pluronic F127

Biomaterials

Volumn 21, Issue 14, 2000, Pages 1483-1491

  Jackson, John K ^a   Springate, Christopher M K ^a,b   Hunter, William L ^c   Burt, Helen M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ARTHRITIS RESEARCH CENTRE OF CANADA   (Canada)

^c Angiotech Pharmaceuticals Inc   (Canada)

Author keywords

Neutrophil activation; Opsonization; Pluronic F127; Polymer microspheres

Indexed keywords

BIOCOMPATIBILITY; BLOOD; CELLS; COPOLYMERIZATION; IMMUNOLOGY; PARTICLE SIZE ANALYSIS; PLASTIC PRODUCTS; POLYETHYLENES; POLYMETHYL METHACRYLATES; POLYSACCHARIDES; POLYVINYL ACETATES; PROTEINS;

NEUTROPHIL ACTIVATION; PLASMA OPSONIZATION; POLYCAPROLACTONE; POLYLACTIC ACID; POLYMERIC MICROSPHERES;

BIOMATERIALS;

BIOMATERIAL; ETHYLENE VINYL ACETATE COPOLYMER; IMMUNOGLOBULIN G; MICROSPHERE; POLOXAMER; POLY(METHYL METHACRYLATE); POLYCAPROLACTONE; POLYLACTIC ACID; POLYMER; POLYVINYL ALCOHOL; SUPEROXIDE;

ADSORPTION; ARTICLE; BIOCOMPATIBILITY; CHEMOLUMINESCENCE; CONTROLLED STUDY; ELECTROPHORESIS; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INFLAMMATION; LEUKOCYTE ACTIVATION; NEUTROPHIL; OPSONIZATION; PARTICLE SIZE; PHAGOCYTOSIS; PLASMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERIZATION; PRIORITY JOURNAL;

BIOCOMPATIBLE MATERIALS; HUMANS; KINETICS; LACTIC ACID; MICROSPHERES; NEUTROPHIL ACTIVATION; NEUTROPHILS; PHAGOCYTOSIS; POLOXAMER; POLYESTERS; POLYMERS; POLYMETHYL METHACRYLATE; SUPEROXIDES; SURFACE-ACTIVE AGENTS;

EID: 0034055487     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(00)00034-X     Document Type: Article

References (40)

1. Heya T., Okada H., Ogawa Y., Toguchi H. Factors influencing the profiles of TRH release from co-poly(D,L-lactic/glycolic acid) microspheres. Int J Pharm. 72:1991;199-205.
2. Maincent P., Thouvenot P., Amicabile C., Hoffman M., Kreuter J., Couvreur P., Devissaguet J. Lymphatic targeting of polymeric nanoparticles after intraperitoneal administration in rats. Pharm Res. 9(12):1992;1534-1539.
3. Pavanetto F., Genta I., Giunchedi P., Conti B., Conte U. Spray-dried albumin microspheres for the intra-articular delivery of dexamethasone. J Microencapsulation. 11:1994;445-454.
4. Ratcliffe J.H., Hunneyball I.M., Smith A., Wilson G.G., Davis S.S. Preparation and evaluation of biodegradable polymer systems for the intraarticular delivery of drugs. J Pharm Pharmacol. 36:1984;431-436.
5. Mumper R.J., Mills B.J.A., Ryo U.Y., Jay M. Polymeric microspheres for radionuclide synovectomy containing neutron-activated holmium-166. J Nucl Med. 33:1992;398-402.
6. Hunneyball I.M. Intra-articular administration of drugs. Pharmacy Int. 5:1986;118-122.
7. O'Hagan D.T., Rafferty D., Wharton S., Illum L. Intravaginal immunization in sheep using a bioadhesive microsphere antigen delivery system. Vaccine. 11(6):1993;660-664.
8. Anselme K., Flautre B., Hardouin P., Chanavaz M., Ustariz C., Vert M. Fate of bioresorbable poly(lactic acid) microbeads implanted in artificial bone defects for cortical bone augmentation in dog mandible. Biomaterials. 14(1):1993;44-50.
9. Menei P., Daniel V., Montero-Menei C., Brouillard M., Pouplard-Barthelaix A., Benoît J.P. Biodegradation and brain tissue reaction to poly(D,L-lactide -co-glycolide) microspheres. Biomaterials. 14(6):1993;470-478.
10. Kim C-K., Hwang S-J., Lee M.G. The organ targetability of small and large albumin microspheres containing free and HSA conjugated methotrexate. Int J Pharm. 89:1993;91-102.
11. Grandfils C., Flandroy P., Nihant N., Barbette S., Jérome R., Teyssié P.H., Thibaut A. Preparation of poly(D,L)-lactide microspheres by emulsion-solvent evaporation, and their clinical applications as a convenient embolic material. J Biomed Mater Res. 26:1992;467-479.
12. Spenlehauer G., Veillard M., Benoît J-P. Formation and characterization of cisplatin loaded poly(D,L-lactide) microspheres for chemoembolization. J Pharm Sci. 75(8):1986;750-755.
13. Lehr C-M., Bouwstra J.A., Tukker J.J., Junginger H.E. Intestinal transit of bioadhesive microspheres in an in situ loop in the rat - a comparative study with copolymers and blends based on poly(acrylic acid). J Control Rel. 13:1990;51-62.
14. Tang L., Lucas A.H., Eaton J.W. Inflammatory responses to implanted polymeric biomaterials. role of surface-adsorbed immunoglobulin G J Laboratory Clin Med. 122(3):1993;292-300.
15. Norman M.E., Williams P., Illum L. Influence of block copolymers on the adsorption of plasma proteins to microspheres. Biomaterials. 14(3):1993;193-202.
16. Tan J.S., Butterfield D.E., Voycheck C.L., Caldwell K.D., Li J.T. Surface modification of nanoparticles by PEO/PPO block copolymers to minimize interactions with blood components and prolong blood circulation in rats. Biomaterials. 14:1993;823-833.
17. Verrecchia T., Spenlehauer G., Bazile D.V., Murry-Brelier A., Archimbaud Y., Beillard M. Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers. J Control Rel. 36:1995;49-61.
18. Bamford C.H., Al-Lamee K.G. Studies in polymer surface functionalization and grafting for biomedical and other applications. Polymer. 35(13):1994;2844-2852.
19. Yamada T., Muramatsu N., Kondo T. Phagocytosis of monosaccharide-binding latex particles by guinea-pig polymorphonuclear leucocytes. J Biomater Sci, Polym Edn. 4:1993;347-355.
20. Ikada Y. Surface modification of polymers for medical applications. Biomaterials. 15:1994;725-736.
21. Harper G.R., Davies M.C., Davis S.S., Tadros Th.F., Taylor D.C., Irving M.P., Waters J.A. Steric stabilization of microspheres with grafted polyethylene oxide reduces phagocytosis by rat Kupffer cells in vitro. Biomaterials. 12:1991;695-700.
22. Rudt S., Müller R.H. In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. III. Uptake of differently sized surface-modified particles, and its correlation to particle properties and in vivo distribution. European J Pharm Sci. 1:1993;31-39.
23. Moghimi S.M., Muir I.S., Illum L., Davis S.S., Kolb-Bachofen V. Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim Biophys Acta. 1179:1993;157-165.
24. Rudt S., Müller R.H. In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. II. Effect of surface modification by coating of particles with poloxamer on the phagocytic uptake. J Control Rel. 25:1993;51-59.
25. Rudt S., Müller R.H. In vitro uptake of polystyrene latex particles and parenteral fat emulsions by human granulacytes. Int J Pharm. 99:1993;1-6.
26. Burt H.M., Jackson J.K. Enhancement of crystal induced neutrophil responses by opsonization of calcium pyrophosphate dihydrate crystals. Ann Rheumatic Dis. 52:1993;599-607.
27. Terkeltaub R., Curtiss L.K., Tenner A.J., Ginsberg M.H. Lipoproteins containing apoprotein B are a major regulator of neutrophil responses to monosodium urate crystals. J Clin Invest. 73:1984;1719-1730.
28. Kaplan S.S., Basford R.E., Jeong M.H., Simmons R.L. Mechanisms of biomaterial-induced superoxide release by neutrophils. J Biomed Mater Res. 28:1994;377-386.
29. Burt H.M., Jackson J.K., Dryden P., Salari H. Crystal-induced protein tyrosine phosphorylation in neutrophils and the effect of a tyrosine kinase inhibitor on neutrophil responses. Mol Pharmacol. 43:1993;30-36.
30. Winternitz C.I., Jackson J.K., Burt H.M. The interaction of monoclinic calcium pyrophosphate dihydrate crystals with neutrophils. Rheumatol Int. 16:1996;101-107.
31. Abbas A.K., Lichtman A.H., Pober J.S. Cellular and molecular immunology. 1991;W.B. Saunders Co, Philadelphia.
32. McCarty D.J. Pathogenesis and treatment of crystal-induced inflammation. McCarty D.J. Arthritis and allied conditions. 1995;1494-1514 Lea and Febiger, Philadelphia.
33. Harper G.R., Davis S.S., Davies M.C., Norman M.E., Tadros T.F., Taylor D.C., Irving M.P., Waters J.A., Watts J.F. Influence of surface coverage with poly(ethylene oxide) on attachment of sterically stabilized microspheres to rat Kupffer cells in vitro. Biomaterials. 16:1995;427-439.
34. Evora C., Soriano I., Rogers R.A., Shakesheff K.M., Hanes J., Langer R. Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry. the effect of 1,2-dipalmitoylphosphatidylcholine J Control Rel. 51:1998;143-152.
35. Lacasse F.X., Filion M.C., Phillips N.C., Escher E., McMullen J.N., Hildgen P. Influence of surface properties at biodegradable microsphere surfaces. effects on plasma protein adsorption and phagocytosis Pharm Res. 15:1998;312-317.
36. Torchilin V.P. Review. polymer-coated long-circulating microparticulate pharmaceuticals J Microencapsulation. 15:1998;1-19.
37. Kushner I., Somerville J.A. Permeability of human synovial membrane to plasma proteins. Relationship to molecular size and inflammation. Arthritis Rheum. 14:1971;560-570.
38. Currey H.L.F., Vernon-Roberts B. Examination of synovial fluid. Jayson M.I.V. Clinics in rheumatic diseases. diagnosis and assessment vol 2:1976;149-177 Saunders, London.
39. Shine B., Bourne J.T., Baig F.B., Dacre J., Doyle D.V. Reactive protein and immunoglobulin G in synovial fluid and serum in joint disease. Ann Rheumatic Dis. 50:1991;32-35.
40. Markowitz H. Synovial fluid proteins. Dalt Y. Proteins in body fluids, amino acids, and tumor markers. diagnostic and clinical aspects:1983;239-253 Liss, New York.